Catalonia.health has established a partnership with EY and the NextHealth series of conferences on innovation in life sciences. These sessions aim to explore the present and future of business transformation.

This second session of the conference series is called “Medicines on route: addressing the challenge and efficiency of pharmaceutical distribution”. The main objective of this meeting is to offer a space for discussion on current issues, focused on the challenges and opportunities presented by the constantly evolving market, and the key strategies that pharmaceutical companies can adopt to improve processes, maximize quality and guarantee their business.

In this second session on the challenge and efficiency of pharmaceutical distribution, we will address crucial aspects such as third-party control in terms of distribution, control of the correct supply and supply of the market, securing agreements and effective trade strategies.

Programme

9:15 h | Arrival and registration

9:30 h | Welcome

• Hugo Dosil, Partner in charge of the Life Sciences sector EY Business Consulting
• Arantxa Sanz, CEO at Catalonia.Health

9:45 h | The pharmaceutical industry: challenges and opportunities

• Jaime del Barrio, Senior Advisor of the Health and Life Sciences sector at EY

10:00 h | Challenges and solutions in the pharmaceutical supply chain

• Joaquin Castillón Colomina, soci de Risk Consulting de EY
• Pablo Díaz Ortiz, Senior Manager de Risk Consulting de EY

10:30 h | Monitoring tool demo

• Joaquin Castillón Colomina, soci de Risk Consulting de EY
• Pablo Díaz Ortiz, Senior Manager de Risk Consulting de EY

11:00 h | Networking lunch

For: Pharmaceutical companies.

Language: Spanish

Upcoming sessions in EY's NextHealth innovation conference series:

• 14 January - Keys to proper legal and tax governance for pharmaceutical companies at all stages of development.
• 26 February - How is the H&LS sector addressing sustainability challenges?
• 17 March - AI in the pharmaceutical industry: transforming the future of healthcare through artificial intelligence.

Last sessions in EY's NextHealth innovation conference series:

• 28 October - Cybersecurity in the Pharmaceutical Industry